Live Breaking News & Updates on Capecitabine Plus Bevacizumab

Stay updated with breaking news from Capecitabine plus bevacizumab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Andre on the SOLSTICE Trial in mCRC

Thierry Andre, MD, discusses the efficacy of trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer and the safety profiles of the 2 arms of the phase 3 SOLSTICE trial. ....

France General , Thierry Andre , University Pierre Et Marie Curie , Oncology Department , University Pierre , Marie Curie , Medical Oncology Department , Antoine Hospital , Efficacy With , Safety Profiles , Capecitabine Plus Bevacizumab , Trifluridine Tipiracil Plus Bevacizumab , Patients With Metastatic Colorectal Cancer , Solstice Trial , St Antoine Hospital ,